Inhibikase Therapeutics Inc (IKT)
EBITDA Margin
-1953897600.00%
TTM · Period ending:
IKT EBITDA Margin
Latest reported-1953897600.00%period ending
Latest reported-1953897600.00%period ending
IKT TTM EBITDA Margin (-39.12% → -1953897600.00%)
TTM ebitda margin
High-resolution chart · PNG
IKT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -1,953,897,600% | |
| -23,069.114% | |
| -9,705.9991% | |
| -7,236.6545% | |
| -5,848.8661% | |
| -7,489.8204% | |
| -9,328.3487% | |
| -7,102.1525% | |
| -7,267.9187% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -56.523% | |
| -45.0585% | |
| -35.1895% | |
| -39.1152% |